For laboratory research use only · Not for human or veterinary use · 18+
Metabolic research

Buy Survodutide Peptide in Australia

Lyophilised powder, 10mg vial · Price on request
Price to confirm

Buy Survodutide in Australia from Macropus Peptides as a 10mg research vial, priced by quote until a list price is confirmed. Survodutide is a long-acting peptide based on the glucagon sequence and modified to add GLP-1 receptor activity, so a single molecule works at both the glucagon receptor and the GLP-1 receptor. Its glucagon arm acts mainly in the liver, which is why its published record leans toward hepatic research. The vial holds research-grade lyophilised powder under a crimped seal, labelled with compound, strength, lot number and storage temperature, and every lot has a certificate of analysis on request. Ask for a quote, add bacteriostatic water, and the order is dispatched from inside Australia to any address in the country. Survodutide is sold for in-vitro laboratory research only, to buyers aged 18 and over, and must not be used in people or animals.

1
Frequently bought together
Mazdutide 10mgPrice to confirm
For in-vitro laboratory research only. Not for human or veterinary use. Purchasers must be 18 or over.
CompoundSurvodutide
Amount10 mg
FormLyophilised powder
CategoryMetabolic research
Storage-20 °C, protect from light
TestingHPLC purity and mass spectrometry identity, every batch
Certificate of analysisAvailable for every lot, matched to the lot number on the label
Peptide calculator

Survodutide 10mg vial

Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.

Vial content
10 mg
mg per mL5.00
mcg per mL5,000

Buy Survodutide Australia: 10mg Research Vial

Macropus Peptides carries this glucagon and GLP-1 receptor dual agonist as a single 10mg vial of freeze-dried peptide. It stays on quote until a list price is fixed, and all stock traces to one managed source with its lot code on the glass.

Survodutide Australia: what is Survodutide

Survodutide, coded BI 456906 during development, is a synthetic peptide derived from the sequence of glucagon, the pancreatic hormone that raises glucose output from the liver. Targeted substitutions give the chain strong activity at the GLP-1 receptor while keeping glucagon receptor activity, and they also improve its stability, since native glucagon tends to form fibrils in solution. A C18 fatty acid attached to the chain binds albumin, so the peptide circulates for days rather than minutes. It reached phase 3 clinical study, with a separate programme focused on liver disease.

Survodutide peptide in liver and incretin research

Glucagon receptors are most dense on hepatocytes. Activating them increases glucose release, amino acid uptake and fatty acid oxidation in the liver, and in rodents it raises whole-body energy expenditure. The GLP-1 receptor side contributes glucose-dependent insulin release and signalling in appetite centres of the brain. Pairing the two in one molecule lets researchers study how hepatic glucagon signalling interacts with incretin signalling without a GIP component. Compared with Mazdutide, which shares the same receptor pair, this peptide differs in sequence origin, lipidation and receptor balance, so the two are often run in parallel to see which differences matter in a given assay.

Survodutide research: what the published studies show

Its discovery and preclinical pharmacology were published in Molecular Metabolism in 2022, covering receptor potency at both targets and energy expenditure in rodent models. In 2024, The Lancet Diabetes and Endocrinology published a phase 2 trial comparing several exposure levels against placebo, and a phase 2 trial in metabolic dysfunction-associated steatohepatitis, published in NEJM, measured liver histology on biopsy. That liver emphasis reflects where glucagon receptor activity is concentrated. Every study is described in our Survodutide research studies library.

Survodutide vial specifications

SpecificationDetail
CompoundSurvodutide
Amount10 mg
FormLyophilised powder
CategoryMetabolic research
Storage-20 °C, protect from light

The glucagon-derived peptide arrives as a compact white cake in crimp-sealed glass. Its wraparound label records name, 10mg strength, batch number and freezer temperature, and the certificate for that batch is yours on request. Store it unopened at -20 °C with no light exposure.

Survodutide price in Australia

OptionPrice
Survodutide 10mgPrice to confirm

The 10mg vial currently shows price to confirm. Request a quote and we send the figure for the batch on hand, which makes the cost per milligram a simple division by ten when you compare it with other glucagon-containing agonists.

Survodutide 10mg: where to buy in Australia

One vial supports a receptor activation panel, a head-to-head arm against another dual agonist or an assay development series. Keeping a whole comparison on one batch removes a variable from the analysis. Working strengths once dissolved:

  • 1 mL: 10 mg per mL
  • 2 mL: 5 mg per mL

Best place to buy Survodutide Australia

  • A glucagon-based dual agonist with a strong liver research record
  • Quotes matched to the batch in our Australian stock
  • Batch number on the label, tied to its certificate
  • Posted within Australia, so no overseas customs delay
  • Other dual and triple agonists for comparator arms

Survodutide how to get: buy Survodutide online

  • Choose the 10mg vial and request pricing
  • Approve the quote and pick a quantity
  • Ask for bacteriostatic water on the same order
  • Pay once adult age and research use are confirmed
  • Note the batch on delivery for the certificate request

Survodutide calculator: bac water and stock strength

Enter a diluent volume into the listing's calculator and it reports the resulting strength in milligrams and micrograms per millilitre. Reference points for this vial:

  • 1 mL: 10 mg per mL
  • 2 mL: 5 mg per mL
  • 4 mL: 2.5 mg per mL

Glucagon-derived sequences are prone to fibrillation, so add bacteriostatic water slowly, roll rather than shake, and keep the solution chilled. More diluents are in lab supplies.

Is Survodutide available in Australia

It is offered purely as research material. The peptide is missing from the ARTG and holds no TGA approval of any kind, so humans and animals are off limits, and every sale is for in-vitro laboratory research. Since the Poisons Standard is updated regularly, check how it currently handles research peptides for your organisation before ordering.

Survodutide for sale Australia wide

Orders are packed in Australia for research addresses across the mainland and Tasmania, each vial held upright with its seal protected. Laboratories building a glucagon comparison usually add Mazdutide and Retatrutide, and the rest of the metabolic research range is one click away.

References

  1. BI 456906: discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy. Molecular Metabolism. 2022.
  2. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial. The Lancet Diabetes and Endocrinology. 2024.
  3. A phase 2 randomized trial of survodutide in MASH and fibrosis. New England Journal of Medicine. 2024.

Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.

Questions about Survodutide 10mg

Chat on WhatsApp
Survodutide 10mgPrice to confirm